FormWeb • valGANciclovir

Approved Hospital Formulary

Formulary Addition Requisition (Position 1)

Add Formweb to your mobile device

Android iOS

Approved Hospital Formulary

Formulary Addition Requisition (Position 1)

valGANciclovir

Drug Name	Form	Strength	Non-Formulary	Restricted	Renal Dosing	REMS	Therapeutic Interchange	Notes
ValGANciclovir Hydrochloride	POWDER FOR RECONSTITUTION, ORAL	50 mg/mL
Valcyte	TABLET, ORAL	450 mg

Additional Information:

Drug Name	Common Side Effects
valganciclovir	GI: nausea, vomiting, diarrhea fever muscle twitching

Last updated: Sep. 23, 2022

Black Box Warning: Hematologic Toxicity; Impairment of Fertility; Fetal Toxocity; Mutagenesis & Carcinogenesis
Do Not Crush: Tablet - Note: Teratogenic and irritant potential (i,b)
Hazardous Drugs: Group 2 (NIOSH 2016)
Hazardous Drugs: Table 1 (NIOSH 2020)
Restricted: ID approval needed. Exception: Unrestricted use for solid organ and bone marrow transplant patients.

Rhazdrugs: valGANciclovir

For further information regarding Formweb
please call 800.467.1907.